Keros Therapeutics (KROS) Cash from Operations (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -940.01% |
| Sep 30, 2025 | 110.97% |
| Jun 30, 2025 | -118.38% |
| Mar 31, 2025 | 450.31% |
| Dec 31, 2024 | -50.85% |
| Sep 30, 2024 | 23.37% |
| Jun 30, 2024 | 10.68% |
| Mar 31, 2024 | -75.03% |
| Dec 31, 2023 | 25.08% |
| Sep 30, 2023 | -10.22% |
| Jun 30, 2023 | 9.94% |
| Mar 31, 2023 | -59.66% |
| Dec 31, 2022 | 12.84% |
| Sep 30, 2022 | -8.91% |
| Jun 30, 2022 | -1,483.04% |
| Mar 31, 2022 | 92.71% |
| Dec 31, 2021 | -35.48% |
| Sep 30, 2021 | 18.12% |
| Jun 30, 2021 | -67.89% |
| Mar 31, 2021 | -31.46% |
| Dec 31, 2020 | 26.39% |
| Sep 30, 2020 | -9.36% |
| Jun 30, 2020 | -22.25% |
| Mar 31, 2020 | -47.69% |
| Dec 31, 2019 | -86.06% |
| Sep 30, 2019 | 41.28% |
| Jun 30, 2019 | -100.24% |